Does increased urinary interleukin-1 receptor antagonist/interleukin-1beta ratio indicate good prognosis in renal transplant recipients?

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Transplantation

• Publication date

  1998-10-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199810270-00008PMID 9808484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monocytes-macrophages and cytokines/chemokines in fine-needle aspiration biopsy cultures: enhanced interleukin-1 receptor antagonist synthesis in rejection-free kidney transplant patients.

  1997cited by this paper
• New insights into therapy with monoclonal antibodies in allograft transplantation.

  1997cited by this paper
• Topical interleukin 1 receptor antagonist promotes corneal transplant survival.

  1997cited by this paper
• Interleukin-1 receptors and receptor antagonist in haemodialysis.

  1997cited by this paper
• Interleukin-1 receptor antagonist: a "novel" acute phase protein with antiinflammatory activities.

  1997cited by this paper
• Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology.

  1997cited by this paper
• Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.

  1997cited by this paper
• Acute rejection of renal allografts: mechanistic insights and therapeutic options.

  1997cited by this paper
• Expression of cytokines, growth factors, and adhesion molecules in rejecting human renal allograft.

  1996cited by this paper
• Gene therapy for rheumatoid arthritis starts clinical trials

  1996cited by this paper
• Serum C-reactive protein. A useful and economical marker of immune activation in renal transplantation.

  1996cited by this paper
• A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease.

  1996cited by this paper
• Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity.

  1995cited by this paper
• Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

  1994cited by this paper
• Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease

  1994cited by this paper
• Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.

  1994cited by this paper
• Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.

  1994cited by this paper
• The role of interleukin-1 in disease.

  1993cited by this paper
• Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis.

  1993cited by this paper
• Induction of circulating IL-1 receptor antagonist by IFN treatment.

  1993cited by this paper
• International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.

  1993cited by this paper
• Interleukin-1 receptor antagonist.

  1993cited by this paper
• Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts.

  1993cited by this paper
• Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist.

  1993cited by this paper
• Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts.

  1992cited by this paper
• Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.

  1992cited by this paper
• Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.

  1992cited by this paper
• IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells.

  1992cited by this paper
• IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells.

  1991cited by this paper
• Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease.

  1991cited by this paper
• HIV isolation from pulmonary cells derived from bronchoalveolar lavage.

  1991cited by this paper
• Production of interleukin-1-receptor antagonist during experimental endotoxaemia.

  1991cited by this paper
• Actin: protein structure and filament dynamics.

  1991cited by this paper
• Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils.

  1991cited by this paper
• Induction of the interleukin 1 receptor antagonist protein by transforming growth factor‐β

  1991cited by this paper
• Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction.

  1991cited by this paper
• Acute‐phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin‐1 and interleukin‐6

  1991cited by this paper
• Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

  1990cited by this paper
• Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.

  1990cited by this paper
• The clinical significance of serum C-reactive protein after renal transplantation.

  1988cited by this paper
• Serum immunoreactive interleukin-1 in renal transplant recipients.

  1987cited by this paper
• Serum immunoreactive interleukin-1 in renal transplant recipients.

  1987cited by this paper
• Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis.

  1987cited by this paper
• Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).

  1986cited by this paper
• Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection.

  1984cited by this paper
• SERUM AMYLOID A PROTEIN: A SENSITIVE INDICATOR OF RENAL ALLOGRAFT REJECTION IN HUMANS

  1983cited by this paper
• Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus.

  1982cited by this paper
• THE BIOLOGY OF SAA: IDENTIFICATION OF THE INDUCER, IN VITRO SYNTHESIS, AND HETEROGENEITY DEMONSTRATED WITH MONOCLONAL ANTIBODIES *

  1982cited by this paper
• Fine-needle aspiration biopsy in the diagnosis of human renal allograft rejection.

  1973cited by this paper
• FEMORAL NECK FRACTURES.

  1964cited by this paper

• Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation

  2023cites this paper
• The role of uropathogenic Escherichia coli adhesive molecules in inflammatory response- comparative study on immunocompetent hosts and kidney recipients

  2022cites this paper
• Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats.

  2019cites this paper
• Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?

  2018cites this paper
• Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature

  2017cites this paper
• Macrophages in renal transplantation: Roles and therapeutic implications.

  2014cites this paper
• Lymphangiogenesis in renal inflammation and transplantation

  2013cites this paper
• The Role of Macrophages in Transplant Rejection

  2012cites this paper
• Macrophages and kidney transplantation.

  2010cites this paper
• Decreasing plasma soluble IL‐1 receptor antagonist and increasing monocyte activation early post‐transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients

  2009cites this paper
• IgA nephropathy and Henoch-Schönlein nephritis in adults : with special reference to factors affecting outcome

  2006cites this paper
• Production of IL-1Ra by human mononuclear blood cells in vitro: influence of serum factors.

  2006cites this paper
• The Role of Macrophages in Allograft Rejection

  2005cites this paper
• Quantitative detection of changes in cytokine gene expression in peripheral blood mononuclear cells correlates with and precedes acute rejection in renal transplant recipients.

  2005cites this paper
• Activation of Pro‐Inflammatory and Anti‐Inflammatory Cytokines in Host Organs During Chronic Allograft Rejection: Role of Endothelin Receptor Signaling

  2005cites this paper
• Post‐transplant C‐reactive protein monitoring can predict chronic allograft nephropathy

  2004cites this paper
• Lower urinary-interleukin-1 receptor-antagonist excretion in IgA nephropathy than in Henoch-Schönlein nephritis.

  2003cites this paper
• Differences in adsorption of serum proteins and production of IL-1ra by human monocytes incubated in different tissue culture microtiter plates.

  2003cites this paper
• Bedeutung von Zytokinen im Aszites und Serum

  2003cites this paper
• Brain cytokines and disease

  2002cites this paper
• The balance between IL-1 and IL-1Ra in disease.

  2002cites this paper
• Urinary markers of renal graft rejection.

  2001cites this paper
• A study of the role of cytokines in acute pancreatitis in man

  2001cites this paper
• Nutritional status and postoperative cytokine response in colorectal cancer patients.

  2000cites this paper
• Interleukin‐1 receptor antagonist in ascites indicates acute graft rejection after pediatric liver transplantation

  2000cites this paper
• Current trends in transplant immunology.

  1999cites this paper